AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

OptimizeRx Corporation (OPRX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

6.20

-0.37 (-5.63%)

At close: Feb 20, 2025, 3:59 PM

6.19

-0.16%

After-hours: Feb 20, 2025, 04:00 PM EST

undefined% (undefined)

Bid	6
Market Cap	114.21M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-1.34
PE Ratio (ttm)	-4.63
Forward PE	n/a
Analyst	Buy

Ask	6.51
Volume	106,153
Avg. Volume (20D)	238,852
Open	6.53
Previous Close	6.57
Day's Range	6.13 - 6.46
52-Week Range	3.78 - 16.65
Beta	undefined

About OPRX

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support mes...

[Show more]

Industry Medical - Healthcare Information Services

Sector Healthcare

IPO Date Nov 28, 2007

Employees 135

Stock Exchange NASDAQ

Ticker Symbol OPRX

Website https://www.optimizerx.com

Full Company Profile

Analyst Forecast

According to 8 analyst ratings, the average rating for OPRX stock is "Buy." The 12-month stock price forecast is $8, which is an increase of 29.03% from the latest price.

Buy 62.50%

Hold 37.50%

Sell 0.00%

Stock Forecasts

Next Earnings Release

OptimizeRx Corporation is scheduled to release its earnings on Mar 27, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

-7.04%

OptimizeRx shares are trading lower after RBC Capi... Unlock content with Pro Subscription

3 months ago

-33.98%

OptimizeRx shares are trading lower after JMP Securities cut its price target on the stock from $16 to $8.

News

2 months ago · https://thefly.com

OptimizeRx initiated with an Equal Weight at Stephens

Stephens initiated coverage of OptimizeRx with an Equal Weight rating and $5.50 price target. The firm says the company's "evolving" direct-to-consumer business model toward self-service may create he...